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unless otherwise stated.arisen, particularly for dialysis therapy. We must make
efforts to promote exchanges in the region, and increase
the standard of dialysis therapy in each country.
With the aim of broadly contributing to the develop-
ment of dialysis therapy in developing countries in Asia,
JSDT launched a “The Committee of JSDT to Support
Dialysis Staffs in the Asian Developing Countries” in
2015. This symposium was designed with the aims of: ex-
ploring the types of dialysis therapy provided, current is-
sues, and individual needs in developing countries in Asia
as well as in those that have shown recent, rapid develop-
ment, such as Thailand, and sharing information to
achieve more effective cooperation among such countries.
Based on the information obtained in this symposium, the
committee is planning to prepare effective programs for
young physicians and paramedics in developing countries.Open Access This article is distributed under the terms of the Creative
e (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use,
, provided you give appropriate credit to the original author(s) and the source,
se, and indicate if changes were made. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Table 2 The kidney transplant started successfully in 1995 by a
joint team. Doctors in Myanmar independently performed
transplants successfully in 1997, and a total of 215 procedures
have done in Myanmar up to May 2015
Joint cases Independent cases Total cases
Government hospitals 24 161 (185)
Private hospital - 30 (30)
Total 24 191 (215)
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developed in Japan, referring to a person who practices
the maintenance and management of medical devices
and uses them to provide patients with treatment. Since
the clinical engineers are currently in demand in other
Asian countries, we stressed to introduce this profession
from Japan in this symposium.
Present status of renal replacement therapy in
Myanmar
Khin Maung Maung Than, Myanmar
Renal replacement therapy (RRT) in Myanmar started in
1970 at a government hospital with one hemodialysis
(HD) machine. Private HD started in 1996, and there are
a small percentage of patients overlapping among gov-
ernment and private centres. Home HD is very rare.
Hemodiafiltration (HDF) machines were introduced re-
cently, but true on-line HDF is not available yet. Con-
tinuous renal replacement therapy (CRRT) was also
introduced a few years ago but was not successful.
Regarding HD status in Myanmar, although the num-
ber of HD centres in districts is greater than in Yangon
(machines numbers are similar), the majority of patients
(925/1284 [72%]) are in Yangon (Table 1).
Continuous ambulatory peritoneal dialysis (CAPD)
started several years ago, but the programme was de-
layed because of a lack of training and resources. The
programme has been re-initiated recently. Live, related-
donor kidney transplant started successfully in 1995 with
five patients at a military hospital by a joint team. Doc-
tors in Myanmar independently performed transplants
successfully in 1997 at Yangon General Hospital (YGH),
and a total of 215 procedures have done in Myanmar up
to May 2015 (Table 2).
Training is usually done internally by experienced
trainers, but there is no regular training programme. Oc-
casional training workshops had been done successfully
at government centres within the last few years. Doctors
and nursing staff were sent abroad at times for proper
training or to attend meetings or conferences.
There are a number of issues for RRT in Myanmar. The
costs of RRT are the biggest issue, because it is usually by
self payment (sometimes partly by the government or non-
governmental organisations [NGOs]). Lack of options andTable 1 The number of HD centres in districts is greater than in
Yangon (machines numbers are similar), the majority of patients
(925/1284 [72%]) are in Yangon
Yangon Districts
Government Private Total Government Private Total
Centres 4 13 (17) 15 16 (31)
HD machines 35 101 (136) 49 60 (109)
Patients 183 742 (925) 179 180 (359)choices for patients are also present (HD is still the pre-
dominant form of RRT available). Availability of resources
(funding, equipment, and disposables) is still insufficient,
and there is great disparity between Yangon and other dis-
tricts. Awareness of chronic kidney disease (CKD)/ESRD in
general and its treatment options are poor among the pub-
lic. Quality assurance of the centres and staff is also an im-
portant issue that needs to be solved.
The average cost of an HD session in Myanmar is about
US$ 40, and to bring down the cost further is not straight-
forward. A reimbursement system is required and medical
insurance urgently needed. The role of NGOs may be im-
portant in this matter. As for other options in RRT, the
CAPD programme needs further development and en-
couragement. Renal transplant cases need to be increased
in both the government and private sectors (expanding
donor pools and starting cadaveric programmes will be
helpful). HDF/CRRT should be for selected cases only.
Government spending on the healthcare budget has in-
creased significantly in the last few years, and equipment
is becoming more easily available with reduced costs
owing to competition among distributors. However, more
centres and machines are needed in the districts to reduce
the extra costs and burdens for patients.
Increasing public awareness of CKD/ESRD and RRT is
essential and health education to be given whenever pos-
sible. (World Kidney Day events have been done in Yangon
and Mandalay since 2006, and these should be expanded to
other big cities in the future). For quality assurance in the
centres, regular training programmes are needed, together
with regular audits of the centres as well as staff.
Overall, the outlook for the future of RRT in Myanmar
seems to be promising!
The present status of renal replacement therapy,
quality of water and dialysate, and staff
education in Vietnam
Do Gia Tuyen, Vietnam
Introduction
Chronic renal failure is a devastating medical, social, and
economic problem for patients and their families in
Vietnam. Reliable data on the true incidence and preva-
lence of ESRD in Vietnam are lacking because no na-
tional registries exist. Because a national registry of
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present only limited data in this report.
Overview of Vietnam
The population of Vietnam in 2013 was 90 million, with
25% of people living in urban areas and 75% in rural.
The area of the country is 332,000 km2, divided into 63
provinces. The population growth rate is 1.5% per a year,
and 54 million people are of working age. Gross domes-
tic product (GDP) per capita is US$ 1900. Insurance
covers 65% of population, and the health premium for a
monthly salary is 4.5% at minimum. There are 6.5 doc-
tors and 8.0 nurses per 10,000 inhabitants.
Structure of diseases
Economic growth, an aging population, and lifestyle
changes are leading to an increasing burden of non-
communicable diseases. As for cancer, Vietnam reports
about 75,000 new cases of cancer per a year. The case–
fatality rate is high, and cancer accounts for around 12%
of total deaths annually in Vietnam. Vascular heart dis-
eases are also common, and myocardial infarction is
now one of leading causes of mortality.
ESRD in Vietnam
In Vietnam, 6 million (6.73%) of the general population
have been estimated to be diagnosed with chronic kid-
ney disease. Of these 6 million patients, 80,000 (1.3%)
patients have already reached ESRD. Annually, 8000 pa-
tients are newly diagnosed, of whom 104 (1.3%) will also
go on to require HD services. The number of ESRD pa-
tients on HD was estimated as 10,338. ESRD and treat-
ment methods consist of 87% receive HD, 8.7% receive
CAPD, and 4.3% receive renal transplantation.Fig. 1 The distribution of dialysis population. The peak ages of HD patientsHemodialysis in Vietnam
HD costs US$ 5000 per patient per year and CAPD is
UD$ 6000. There are 130 dialysis centres in Vietnam, and
31 centres among these can perform CAPD. There are 70
centres in the northern part of Vietnam, 25 in the central
part, and 35 in the southern part. In total, 56 centres are
located in the provinces and 64 in cities. Of the provincial
centres, 31, 11, and 14 centres are in the northern, central,
and southern parts of Vietnam, respectively. The total
number of HD patients is 10,338, of whom 4781, 1232,
and 4325 patients are in the northern, central, and south-
ern parts of Vietnam, respectively. The causes of renal dis-
ease for patients on HD consist of 74% due to diabetic
nephropathy, 9% chronic glomerular nephritis, 8% kidney
stone, 3% hypertension, 3% polycystic kidney disease, and
2% other causes. The peak ages of HD patients are 46–55
years old [Fig. 1]. The number of HD machines in
Vietnam is 1807, with 916, 207, and 684 machines are in
the northern, central, and southern parts of Vietnam, re-
spectively. The most common utilization rate of HD ma-
chine is 3 sessions per a day and the other is 4 sessions. In
total, 74.6% machines were rented, 18.0% were bought by
the state budget, and 7.4% were donated.
All HD facilities had RO (reverse osmosis) systems and
used a bicarbonate dialysate. Low-flux dialyzers accounted
for 70% and were reused six times, middle-flux dialyzers
accounted for 20% and reused six times, and the high-flux
dialyzers for 10% and reused 10–12 times. The dialyzers
were sterilized using formalin/Hemoclin. The blood cir-
cuit lines were disposable or reusable. The arterio-venous
fistula needles were disposable.
The standard HD conditions in Vietnam were as fol-
lows. The frequency was 4 h × 3 sessions/week, blood
flow 250–300 mL/min, dialysate flow 500 mL/min, and
the ultrafiltration rate 0.5–1.0 L/hour. KT/V was 1.2–1.3in Vietnam is 46–55 years old
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low molecular weight heparin was used for anticoagula-
tion. Dialysate was bicarbonate and the ultrafiltration co-
efficient (Kuf ) of the dialyzer 5.0–50 mL/mmHg/h. The
reuse of dialyzer was indicated for 98% of patients.Medications prescribed in HD
The medications that are paid for by health insurance
are as follows: anticoagulation medications: heparins
(mostly), which are imported from Europe and India;
Erythopoietin (Eprex, Neo-recomon, Epokin and etc.)
16,000–18,000 units/month; Intravenous iron therapy
(Venofer, Cosmofer, and etc.); and Nephosteril (supply
of amino acids).Other dialysis modalities
Online hemodiafiltration (HDF) treatment has been per-
formed Vietnam since 2011. At present (2015), online
HDF is used in many hospitals in Vietnam, and health
insurance partly covers online HDF.Quality of dialysis: current situation
The quality of each HD session is questionable. In general,
it was not qualified, and KT/V ~1.0 (URR 50–60%) was
common. “Dry weight” management was not good. The
causes were as follows. The time length of HD was not
enough, mostly 3.5 hours/session and even rarely 3.0 h/
session in some centers. Overall, 70% of dialysis centers
used low-flux membranes with Kuf = 5.6–6.5. In addition,
the system to clean the dialyzer was not modern enough,
which caused difficulty in managing the quality of reusable
dialyzers. The HD reimbursement from insurance in each
session was too low (US$ 23), and equipment costs have
increased to 10% every year. The dialysis centers were
forced to reduce the hours of HD, reduce dialysate, use
cheaper and more frequently reused dialyzers.Anemia management in HD patients
Erythropoietin 2000 IU was injected subcutaneously
after a HD session. Iron of 100 mg (Venefer) per month
was also injected intravenously after the session. The tar-
get Hb level was 11.0–12.0 g/dL. Blood infusion is re-
stricted if possible. However, it is estimated that only
60–70% of patients achieved the target outcomes. Thera-
peutic doses of erythropoietin depended on the ceiling
of insurance. There were many patients with insufficient
medication (only 16,000 IU/month). Combined medica-
tions were not effective because of limitations in labora-
tory tests. The poor quality of HD negatively impacted
on the effectiveness of dialysis therapy. The quality of
erythropoietin was not equal because too many kinds of
products were in use.Other problems
There were a number of limitations in nutrition for dialy-
sis patients. Nutritional consultation was the most com-
mon method. A diet menu for dialysis patients has not
been issued, and most patients did not comply nutritional
regimens. Malnutrition and excessive water intake were
common in dialysis patients. In addition, the management
co-morbid diseases caused substantial difficulties.
Hypertension management was poor, because anti-
hypertensive medications were not paid for by health in-
surance. The lack of specialist doctors is another big
problem. Diabetes management is very difficult and dia-
betic medications are not paid for by health insurance.
The calcium–phosphorus – PTH (parathyroid hor-
mone) level management is not considered adequate in
most of dialysis centres.
Water quality
In Vietnam, 100% of dialysis centers have RO systems.
However, the quality of water in RO systems was poor be-
cause the regeneration time for RO membranes was infre-
quent. In addition, the recommended frequency of
maintenance was not implemented. Water quality, in terms
of the chemical and microbial indicators, was not assessed
periodically. Most dialysis centers did not have technicians
or clinical engineers undertaking RO system maintenance.
The endotoxin (ET) levels in RO water were accept-
able at only two among four facilities in the survey with
Japanese team. ET levels in dialysis fluids were assessed
in standard dialysis. The ET levels in standard dialysates
were satisfactory at only one location. The bacterial
counts in RO water were acceptable only one other loca-
tion. The bacterial counts in dialysates were not accept-
able at any of the locations investigated. In RO water
and standard dialysate, the ET level should be <50 EU/L
and the bacterial count <100 colony-forming units
(CFU)/mL. In ultrapure dialysate injected directly into
the human body (e.g., for online HDF), the ET level
should be <1 EU/L (less than the detectable limit) and
the bacterial count <0.1 CFU/mL.
Solutions for improving patient’s quality of life in Vietnam
To improve outcomes during HD sessions in Vietnam, it
seems the following changes are needed: the use high-
flux membranes and avoidance of reusing low-flux
membranes; HD frequency needs three sessions per
week, with 4–5 h per session, KT/V of 1.2, and the URR
of 60–70%; and improvement of the quality of water
sources and dialysate, and the quality of HD machines
combined with other modalities such as online HDF.
CAPD: current situation
The prevalence of CAPD accounted for 15.4% of RRT
patients. CAPD costs were UD$ 6000 per patient per
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Company. The most common CAPD complications in-
clude infection around the catheter site or peritonitis.
Kidney transplantation
A total of 1011 kidney transplantation took place. Of
these, living donors accounted for 95% and only 5% from
brain-dead donors. Most donors were related to the pa-
tient and less than 60 years old. The graft survival rate for
more than 1 year was 95%, and for more than 5 years was
70%. The longest graft survival was 22 years. The main
causes of graft loss were infection and chronic rejection.
The medications are covered by health insurance.
Staff education of renal replacement therapy
None of the hospitals in the provinces had a Nephrology
department. Of centers with a working Nephrology de-
partment, the medical doctors who work there were not
always nephrologists or trained in nephrology, and the
nurses were not educated systemically in nephrology.
Most dialysis centers were located in hospitals, and the
dialysis facilities were developed before the nephrology
department was established. Most physicians in HD cen-
ters were general doctors with a short duration of train-
ing in dialysis but not in nephrology generally. Most HD
centers did not have clinical engineers.
An update on renal replacement therapy in
Thailand
Korntip Pattanasittangkur, Thailand
PD first policy era
RRT in Thailand has been increasingly widespread since
National Health Security Office (NHSO) launched the
Peritoneal Dialysis (PD) First Policy under Universal
Healthcare Coverage Scheme (UCS) in 2008. CAPD has
been chosen as the first choice of dialysis because it is
potential cost-saving, simplier, more feasible, and require
less infrastructure. Comparing data between CAPD and
HD in UCS, the number of CAPD patients is growing
rapidly and nearly equal to the number of HD patients.
Problems resulting from rapid increase in CAPD patient
numbers are a lack of PD trained staffs, an insufficient
number of CAPD centers, and CAPD-related co-
mplication. Outcome data have been collected on tech-
nical value and patient survival. Currently, there is no
data on cost-effectiveness. Moreover, HD units expand
continuously for new ESRD patients and for patients
who are not suitable for CAPD program.
Quality of water for hemodialysis and dialysate
Water for HD remains a huge problem for quality control
because the water supply is quite different across Thailand
such as bypass water from sideway due to shortage of
rainwater, seasonal high tides of seawater in the centralpart of the country and using groundwater supply in some
northeastern areas. Monitoring of RO water and dialysate
quality for trace elements, bacteria contamination and en-
dotoxins is necessary, but there are variations in monitor-
ing frequency and testing techniques especially in HD
units that are far away from laboratory centers.
Present and future challenge
Although universal RRT penetration and dialysis tech-
niques have improved, unplanned dialysis is still a major
problem because of patient denial. The challenge is to
communicate the benefits of PD therapy to healthcare
workers, patients and their families. The Ministry of
Public Health has acknowledged this issue and imple-
mented CKD clinic to cover prevention along with pro-
moting renal transplantation as the most cost-effective
therapy. RRT in Thailand is now in developing as a
strategy to improve prevention and treatment for the en-
tire Thai population.
Status of hemodialysis in Beijing and impact of
staff continuous medical education and labor
intensity
Liu Wen Hu, China
Present status of RRT in China
The number of patients with CKD has been increasing
worldwide. Similar to other developed countries, CKD
patients have already reached 10.8% of the total popula-
tion in China. However, with a huge population of more
than 1.3 billion, this equates to 130 million CKD pa-
tients. In the coming decades, there will be more than 1
million patients with ESRD, which will impose a huge
burden on government healthcare budgets. Even so,
there are still many counties across China without HD
centers. The causes of this situation include economic,
traffic, medical support, and educational reasons, among
others. The central government has launched a major
project to reach such patients, especially in rural or re-
mote areas. The number of patients receiving mainten-
ance HD has increased rapidly due to government
support. The number of HD patients was 234632 in
2011, 248016 in 2012, 283581 in 2013, and 339227 in
2014. However, there are still differences in prevalence
among provinces in China.
Present status of RRT in Beijing
More than 90% of RRT occurs in conventional HD cen-
ters. The mean quantity of blood flow (QB) was 265 ml/
min, and the quantity of dialysate (QD) was 500 ml/min.
In total, 92% of patients had an arterio-venous fistula.
More than 86% of all dialyzers used polysulfone mem-
brane with an area of 1.3–1.6 m2, and more than 50%
was high-flux membrane. Endotoxin levels of the dialys-
ate were less than 0.25 EU/ml. A central dialysate
Table 3 The blood tests performance rate (%) per a year for
each element among three hospital level groups
Hospital A Hospital B Hospital C
Hb 70.69 88.19 79.00
Ferritin 14.40 70.75 59.80
Ca 69.15 85.68 78.02
Phosphorus 68.89 85.13 77.80
iPTH 57.84 78.90 71.40
Alb 43.70 60.79 60.47
Kt/V 43.70 60.79 60.47
Urea reduction rate 53.98 74.39 56.98
Table 4 The rates (%) of fulfillment for the target test frequency
per a year
Hospital A Hospital B Hospital C
Hb (6 times/year) 39.85 44.92 32.73
Ferritin (3 times/year) 0.77 33.45 33.91
Ca (6 times/year) 36.25 35.41 27.35
Phosphorus (6 times/year) 35.99 35.39 26.85
iPTH (4 times/year) 18.51 24.84 25.28
Alb (4 times/year) 24.16 25.97 22.14
Kt/V (4 times/y) 24.16 25.97 22.14
Urea reduction rate (4 times/year) 28.53 34.86 19.82
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centers in Beijing was 110 in 2011, 109 in 2012, 110 in
2013, and 110 in 2014, although military hospitals were
not included in these numbers. The total number of HD
centers in China was 4047, with 2.7% of all HD centers
located in Beijing. The number of HD patients in Beijing
was 12,696 in 2011, 9362 in 2012, 8914 in 2013, and
10,029 in 2014, but patients attending military hospitals
were not included. The total number of HD patients in
China was 339,227 in 2014, and 2.9% of all HD patients
lived in Beijing. The leading causes of new ESRD pa-
tients in 2014 were chronic glomerulonephritis (43.62%),
diabetes mellitus (DM) (21.15%), and hypertension
(8.77%), of which DM was the second leading cause. The
leading causes of total mortality of patients receiving
maintenance HD (MHD) in Beijing in 2014 were cardio-
vascular events (41.47%), cerebral events (22.39%), and
infection (8.59%). Rates of hepatitis B virus (HBV) infec-
tion in new HD patients in Beijing in 2014 was 7.19%,
hepatitis C virus (HCV) infection 1.30%, syphilis 1.43%,
and human immunodeficiency virus (HIV) infection
0.15%. The prevalence of HBV and HCV infections has
been stable at around 7 and 4%, respectively, among
total MHD patients for the last 4 years.
A survey about the impact of hospital employees on clinical
outcomes of MHD patients in Beijing
Aim of the survey There are three kinds of medical
hospitals in China. Hospital group A comprises commu-
nity public health stations without beds, hospital group
B belongs to the district government each with hundreds
of beds, and hospital group C belongs to the university
or city hall or ministry of health each with thousands of
beds. The aim of this study was to determine whether
there is any difference in clinical outcomes or quality of
HD among the three hospitals groups in Beijing. If there
were any differences, the reasons were elucidated from
the point of view of medical staff.
Materials and methods
Fifteen hospitals were randomly selected from 110 HD
units in Beijing. A questionnaire survey was employed
and clinical parameters were collected from the renal
registry system in Beijing (Table 3). Whether blood tests
for each element were performed and the rates (%) of
fulfillment for the target test frequency were investigated
(Table 4). Additionally, the rates (%) of fulfillment for
the target hemoglobin, serum ferritin, calcium, phos-
phorous, iPTH, and albumin, Kt/V for urea, and urea re-
duction rate were checked (Table 5). The difference in
labor intensity and academic education levels of dialysis
staffs among the three hospitals groups was also investi-
gated. The labor intensity was defined as the number ofdoctors per 100 HD patients. The academic education
levels of dialysis staffs were defined with the best score
of 100 points and the worst of 0 (Table 6).
Results
Whether the blood tests for each element were per-
formed were best in hospital group B, second in hospital
group C, and worst in hospital group A (Table 3). The
rates of fulfillment for the target test frequency varied
among the three kinds of hospital (Table 4). The rates of
fulfillment for the target level of each blood test were
best in hospital group B, second in hospital group C,
and worst in hospital group A (Table 5). The labor in-
tensity for hospital group A was 4.3, B was 6.25, and C
was 1.39. The hospital group C was under the toughest
condition. The continuous medical education (CME)
level of dialysis staffs in the hospital group A was 60
points, B was 90, and C was 93. The CME level of the
staffs in the hospital group C was best (Table 6).
Discussion
The management of the major clinical parameters exam-
ined was better in hospital group B than in hospital
group C. Hospital group C was the poorest in the man-
agement of the major clinical parameters among the
three hospital groups. Community medical stations
Table 5 The rates (%) of fulfillment for the target level for each
test
Hospital A Hospital B Hospital C
Traget level
Hb (100–130 g/L) 54.24 66.00 59.51
Ferritin (100–500 ng/dL) 6.66 39.69 34.64
Ca (2.1–2.5 mmol/L) 37.53 55.72 51.33
Phosphorus (1.13–1.78 mmol/L) 28.02 38.95 36.93
iPTH (150–300 ng/mL) 16.20 23.07 21.56
Alb (>35 g/L) 30.08 35.53 35.17
Kt/V (>1.3) 30.08 35.53 35.17
Urea reduction rate (>67.5%) 29.82 38.66 31.10
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and the poorest education level among the hospital
groups in Beijing. Hospital group C had the highest
CME level and the lowest labor intensity but with poorer
clinical parameters than hospital group B.
Our survey suggested that the CME levels of staff mem-
bers have an impact on major clinical parameters for pa-
tients receiving MHD. The labor intensity might impose a
stronger impact than CME level for the major clinical pa-
rameters in patients receiving MHD. Therefore, in order
to improve the quality of life of patients receiving MHD,
we should employ sufficient numbers of staff and offer
proper CME programs for medical professionals.
Quality of water for renal replacement therapy




The numbers of patients requiring dialysis and dialy-
sis facilities in developing Southeast Asian countries
(e.g., Cambodia, Myanmar, and Vietnam) has increased
annually and are expected to increase in the future [1].
The public insurance system has not been introduced in
Cambodia, and has been partially in Myanmar. And it has
been established in Vietnam. According to the maturation
of the insurance system, the dialysis patients and facilities
have been increasing. The low-flux dialyzers are common
in these countries. The HDF therapy has been partially in-
troduced only in Vietnam. To prevent dialysis-related
complications while performing HDF therapy or whenTable 6 The number of doctors per 100 patients (Labor








Labor intensity (Dr/Pts) 4.30 6.25 1.39
Staff academic education 60 88 90using high-flux dialyzers, or even when using low-flux dia-
lyzers, it is critical to use purified dialysis fluid [2, 3].
The non-governmental organization (NGO) Ubiquitous
Blood Purification International (UBPI) has supported to
purify the dialysis fluid and taught how to do it in these
countries. The NGO UBPI surveyed the dialysis fluid
quality and studied how to keep its quality in these coun-
tries under their own facilities’ conditions. Here, we report
its activity and the results of the study.
Subjects and methods
Dialysis fluid and RO water samples were collected from
dialysis facilities in Myanmar, Cambodia, and Vietnam.
The ET level was determined by means of an ET-specific
limulus reagent (kinetic nephelometry method; Toxin-
ometer ET-Mini and Limulus ES-II plus CS Single Test
Wako; Wako Pure Chemical Industries, Ltd., Tokyo,
Japan). Bacterial number was determined using a con-
ventional plate-counting technique on Reasoner’s 2A
(R2A) agar (Nippon Becton Dickinson Company, Ltd.,
Tokyo, Japan). Each sample was spread on an R2A agar
plate and incubated at room temperature (approximately
25–30 °C) for 7 days. For samples that had not under-
gone the conventional plate-counting technique, bacter-
ial number was determined using the membrane
method, in which 100 mL of sample was filtered through
a cellulose membrane filter (37-mm quality monitor;
diameter, 37 mm; pore size, 0.45 μm; Nihon Pall Co.,
Ltd., Tokyo, Japan). The sample was cultured by pouring
it into tryptone glucose extract broth and incubating at
room temperature (approximately 25–30 °C) for 7 days.
All necessary equipment was imported from Japan, in-
cluding syringes, measuring devices, and culture medium
because of the difficulty in obtaining materials locally.
Results and discussion
At all facilities, the RO water and dialysis fluid demon-
strated high levels of ET and bacterial contamination. For
example, the ET level in dialysis fluid was 0.65 EU/mL
and the bacterial number was >300 cfu/mL at dialysis fa-
cility A in Cambodia. Therefore, we initiated a dialysis
fluid purification project with the NGO UBPI. Further-
more, we have supported the purification of dialysis fluid
in these countries (Fig. 2).
First, for simple contamination control, an ET-retentive
filter (ETRF; CF-609; Nipro Co., Ltd., Osaka, Japan) was
installed in all dialysis consoles. At the same time, flushing
solenoid valves were installed to prevent clogging of the
ETRF. Furthermore, the silicon tube from the ETRF to the
coupler was replaced. After ETRF installation, the ET level
and bacterial number in the dialysis fluid were measured.
The ET levels and bacterial numbers immediately be-
fore/after and approximately 1 year after ETRF installa-
tion are shown in Table 7. The contamination levels of
a b
c d
Fig. 2 Purification support of dialysis fluid by the NGO UBPI. a ET and bacteria measurement. b Installation of ETRF with a flushing solenoid valve
and replacement of the silicon tube. c Dialysis machine after ETRF installation. d Confirmation of dialysis machine operation
Hyodo et al. Renal Replacement Therapy  (2017) 3:11 Page 8 of 14the dialysis fluid at the post-ETRF installation and even
at the re-examination after 1 year fulfilled the water
quality criteria of JSDT (Table 8) [4].
ETRF is very useful to purify dialysis fluid even under
difficult conditions in developing countries. However, be-
cause dialysis fluid demonstrated high levels of ET and
bacterial contamination before filtration, smaller ET and
fine bacterial components as DNA size levels can pass
through the ETRF. Moreover, methods to filter and purify
dialysis fluid and maintain dialysis-related equipment have
not been properly performed. Therefore, the quality man-
agement of dialysis fluid must be standardized in the fu-
ture. Appropriate maintenance of dialysis equipment and
implementation of contamination controls are essential.Table 7 Endotoxin levels and bacterial numbers immediately
before, after, and approximately 1 year after ETRF installation in
Cambodia
Endotoxin (EU/mL) Bacterial colony (CFU/mL)
Before ETRF installation
RO water 0.120 180
Dialysis fluid 0.650 >300
After ETRF installation
Dialysis fluid <0.001 <0.1
Approximately 1
year after ETRF installation
RO water 0.733 >300
Dialysis fluid <0.001 <0.1To do this, local medical staff should be educated regard-
ing quality management of dialysis fluid.
Accordingly, we established the Japanese Assistance
Council of Establishing Dialysis Specialist System (JAC-
DSC) in Cambodia to assist in educating Cambodian
physicians and medical staff (Fig. 3). JAC-DSC provides
training and education regarding dialysis, chronic kidney
disease, renal transplantation, diet therapy for patients
with diabetes mellitus, and clinical engineering.
In Japan, the Clinical Engineers Act was established
approximately 30 years ago to enable clinical engi-
neers to specialize in medical equipment training. In
Japan, the main work of clinical engineers is the oper-
ation and maintenance of medical equipment, includ-
ing life support equipment, such as dialysis machines.
In Japan, clinical engineers are indispensable for en-
suring safe dialysis treatment, including dialysis fluid
purification. Medical instruments have become very
sophisticated and complicated in recent years. In the
future, developing countries will need to organize staff
similar to the clinical engineers in Japan, who have
knowledge of medical science and engineering, to en-
sure appropriate levels of medical care.Acknowledgements
We would like to thank the Japanese clinical engineers
belonging to the NGO UBPI who supported the installa-
tion of the ETRFs as volunteers.





▪ Ultrapure dialysis fluid
Endotoxin: <0.001 EU/mL (less than the detection limit)
Bacteria: <0.1 CFU/mL
This shows indications for dialysis system based on the quality of dialysis
fluids. The standard dialysis fluid is minimum requirement for dialysis therapy.
The ultrapure dialysis fluid is the dialysis fluid for the preparation of online
substitution fluid
Hyodo et al. Renal Replacement Therapy  (2017) 3:11 Page 9 of 14Clinical nutrition education for Japanese
dietitians
Kenichi Miyamoto, Japan
Nutrition and kidney disease
Nutritional management of kidney disease, including
CKD and dialysis, has become increasingly important
[5]. Renal dysfunction has a large effect on nutritional
metabolism. In addition, nutritional care is considered
essential following a diagnosis of CKD. Compelling evi-
dence indicates that the incidence of CKD is increasing
due to the aging population and a higher prevalence of
cardiovascular disease, diabetes, and hypertension [5].
CKD leads to complications such as high blood pressure,
anemia, bone disease, and declining nutritional status
[5]. Nutrition problems associated with kidney disease
include energy intake, proper body weight, salt protein,
and mineral intake [5]. In the USA, to address these
problems, professional programs have been developed to
provide nutritionists with a high degree of knowledge
and experience with regard to kidney disease. In
addition, the American Dietetic Association (ADA) guar-
antees the qualifications of ADA registered dietitians
(RDs) with continuing education requirements [6].
Registered dietitians in the USA
RDs or registered dietitian nutritionists (RDNs) in the USA
receive a high level of education and they are certified by
the ADA [6]. To become an RD or RDN in the USA, it is
necessary to obtain at least a Bachelor’s degree. RDs and
RDNs must also meet current minimum academic require-
ments as approved by the Accreditation Council for Educa-
tion in Nutrition and Dietetics (ACEND) of the Academy of
Nutrition and Dietetics. They must complete a supervised
practical program accredited by ACEND, with a minimum
of 900–1200 clinical hours. They must also successfully
complete the Registration Examination for Dietitians, and
approximately 50% of RDs have advanced qualifications. In
addition, five specialist certifications are available to
professional nutritionists [7]: Kidney nutrition Certified Spe-
cialist (Certified Specialist in Renal Nutrition: CSR), Child
nutrition Certified Specialist (Certified Specialist in PediatricNutrition: CSP), Sports nutrition Certified Specialist (Certi-
fied Specialist in Sports Dietetics: CSSD), Elderly nutrition
Certified Specialist (Certified Specialist in Gerentological
Nutrition: CSG), and Tumor nutrition Certified Specialist
(Certified Specialist in Oncology Nutrition: CSO).
Kidney nutrition certified specialists have at least 2 years’
experience as an RD and at least 2000 hours experience in
the past 5 years with nutritional management of patients
with kidney disease. Once these qualifications are met, the
RD or RDN must pass specialized tests of the ADA Com-
mission on Dietetic Registration. Questions on the exam
range from nephrology to basic knowledge and practical
nutritional management of patients with CKD. In the USA,
dietitians are ranked (Generalist, Specialist, Advanced Prac-
titioner), and the skills, education, and qualification levels
required for each stage have been determined [8].Registered dietitians in Japan
In Japan, there are two types of dietitians: dieticians
and RDs. RDs are responsible for more complicated
tasks than dietitians. Although Japan has a long his-
tory of a formal dietitian system, the education of di-
etitians is based on home economics or agricultural
science, and not medicine. Therefore, they have less
medical knowledge and less clinical experience. In the
general course to obtain an RD license in Japan, clin-
ical training for nutritional management in a univer-
sity requires only ~160 h. International standards,
however, are at least 500 h. As described above, in
the USA, clinical training is at least 900–1200 h. The
clinical training education in Japan is far lower than
the international standard.
Based on the historical background, clinical nutrition
education in Japan is insufficient, particularly clinical
training in hospitals. To improve this situation, the Japan
Dietetic Association and the Japan Society of Metabol-
ism and Clinical Nutrition have launched a program for
RDs to specialize in renal nutrition. A RD specialist that
provides clinical nutritional management is important
for long-term patient care.
Much attention has been paid recently to the nutri-
tional management of disease. Several Asian countries
currently do not have dietitian education programs.
Nutritional management of patients with CKD requires
early disease recognition, appropriate interpretation of
the markers and stage of CKD, and collaboration with
other healthcare practitioners [8–11]. Since 2006, a
number of new international guidelines have been
published or revised using an agreed-upon grading sys-
tem, and together with current literature, should be ap-
plied in dietetic practice, specifically nutritional
interventions or prescriptions administered by clinical
dietitians [8–11].
Fig. 3 Booklet from JAC-DSC intensive seminar
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society for dialysis therapy to the developing
countries of dialysis
Akihiro C. Yamashita, Japan
Introduction
The outcome of Japanese dialysis therapy for ESRD pa-
tients is known to be one of the best in the world. Japan,
however, has not yet contributed much even to neighbor-
ing countries as a leader of dialysis therapy. JSDT estab-
lished an internal committee to support dialysis therapy inso-called developing countries of this treatment. In this
article, introduced is what this committee is planning to
do for those who need any support in dialysis treatment.
Educational and training programs
HD is the most popular treatment modality for ESRD patients
and is an application of membrane separation at which the sol-
ute of interest in blood goes across to the other side of the
membrane where dialysis fluid flows in accordance with the
concentration gradient between these two fluids. Therefore, the
Hyodo et al. Renal Replacement Therapy  (2017) 3:11 Page 11 of 14base of this treatment includes not only “medicine” but also
physics, chemistry and even mathematics. Medical staffs of this
treatment are usually being well trained hands-on and prefera-
bly be familiar with above basic principles.
The committee is established for supporting education of
medical staffs, including young doctors, nurses, clinical engi-
neers (CE), dietitians and other medical staffs with licenses,
in the developing countries of this treatment. The mission
of this committee includes the following four things.
Editing study materials of introduction of dialysis
Starting with the basic principles of dialysis and various
initiatives, we are currently editing several PowerPoint
files of learning material based on the guidelines pub-
lished by JSDT. Each file contains one specific topic and
one slide is designed for a couple of minute-long explan-
ation. Followings are the titles of eleven chapters, show-
ing a model time (= # of slides × 2 min) for a lecture.
I. Introduction of patients to dialysis (1 h)
II. Dialysis prescription (3 h)
III. Peritoneal dialysis (2 h)
IV. Anemia (1 h)
V. Mineral bone disorder (1 h)
VI. Vascular access (1 h)
VII. Water treatment (1h)
VIII. Dialysis fluid (1 h)
IX. Dialysis fluid delivery systems (2 h)
X. Dialyzers (2 h)
XI. Acute kidney injury (2 h)
Hands-on training program in Japanese dialysis centers
We will invite medical staffs to dialysis centers in Japan au-
thorized by JSDT to provide a week-long hands-on trainingFig. 4 Diffusion across a piece of membrane assuming an existence of bou
conservatively assignedwith partial financial aid of \100,000/person by JSDT. Feasi-
bility study of this program has already been done by send-
ing and collecting questionnaires to 454 authorized
hospitals out of total of approximately 4300 dialysis units,
resulting 44 units with affirmative answers to this project.
Curriculum depends on the choice of each trainee and the
venue is assigned where the curriculum is available. We are
expecting 20 trainees to come to Japan each year. For more
information, JSDT’s homepage is available in 2015 or ask
the local academic society of nephrology.
Lectures in dialysis units
Tutors from Japanese hospitals are going to be delegated
to dialysis units to make lectures on dialysis. The topic
of the lectures is determined upon request. This pro-
gram, however, is currently joined and performed to-
gether with the project shown below.
Supporting other individual dialysis support programs
There are several individual programs with similar sup-
port concept of dialysis therapy. Since most of them are
driven with dialysis related companies and/or with dialysis
hospitals, they usually have financially abundant supply.
For example, one of these projects is currently trying to
help establishing a local academic society of nephrology/
dialysis. We are supporting these support programs by en-
dorsing the name of JSDT.
Engineering support program and license
As mentioned previously, it is important to understand
the basic principles of dialysis for further success of the
modality, including physico-chemical structures of the
dialysis membrane, removal mechanism of the treatment
(Fig. 4, from Chapter X of the textbook), disinfectionndary films adjacent to either side of the membrane. Symbols are
Fig. 5 CDDS, the best economical way to treat many patients at the same time
Hyodo et al. Renal Replacement Therapy  (2017) 3:11 Page 12 of 14procedure of the dialysis water supply, including central
dialysis fluid delivery system (CDDS) that is the best eco-
nomical way to treat many patients at the same time with
much less troubles in combination use of “automatic”Fig. 6 Medical team caredialysis consoles (Fig. 5, from Chapter IX of the textbook).
The textbook under edition includes these materials in
addition to the conventional clinical procedures of the
treatment. Understanding and daily maintenance of the
Hyodo et al. Renal Replacement Therapy  (2017) 3:11 Page 13 of 14water purifying and supplying system is especially import-
ant for the safe treatment. For this purpose, these tasks
are assigned to nationally licensed CE in Japan.
Medical team care is important for offering high qual-
ity or more effective medical treatment on the back-
ground of recent medical advancements (Fig. 6). To
achieve this purpose, CE is nationally licensed in Japan
in 1988, following the establishment of “Clinical Engin-
eering Technicians Act” by Ministry of Health, Labor
and Welfare of Japan in the previous year. CE’s are ex-
pected to perform not only blood purification treatment
but also all other medical device-related affairs. Follow-
ing list covers the roles of CE’s. They sometimes move
between departments in the occasion of the regular in-
ternal transfer like nurses.
i. Maintenance and management of medical devices
A)Check/adjustment/exchange/repair/and operation
of the medical devices and safety education to
medical staffs, giving information of medical
devices.
B) Technological assistance and consultation of the
purchase of medical devices.
ii. Operation of the life-support devices
A) Supporting respiratory therapy, blood purification
therapies including HD.
B) Assisting circulation with heart-lung machine,
cardiac catheterization etc.
Conclusions
JSDT will provide educational and training programs for
those who need help especially in Asian countries. Japa-
nese dialysis treatment has been developed in a different
way to the USA and European counterparts. For ex-
ample, CDDS has been believed to be a classic system in
the USA and European countries. It is, however,
employed in most dialysis units in Japan and is one of
the keys of good clinical outcomes. CE’s, who have been
well-educated in vocational schools or universities, have
significant roles for maintaining the quality of Japanese
dialysis treatment.
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